Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$491M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Apple
AAPL
|
+$346M |
| 4 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$333M |
| 5 |
Cisco
CSCO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$409M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$374M |
| 3 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$347M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$343M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Financials | 12.41% |
| 3 | Healthcare | 11.8% |
| 4 | Consumer Discretionary | 10.03% |
| 5 | Industrials | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGMO
2976
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $656K | ﹤0.01% |
1,206,879
+15,677
| +1% | +$7.23K |
|
2977
Lincoln Educational Services
LINC
$946M
| $655K | ﹤0.01% |
65,217
-2,742
| -4% | -$25K |
|
2978
Park-Ohio Holdings
PKOH
$706M
| $653K | ﹤0.01% |
24,235
+1,112
| +5% | +$26.3K |
|
|
DNMR
2979
DELISTED
Danimer Scientific, Inc.
DNMR
| $650K | ﹤0.01% |
15,927
-1,637
| -9% | -$89K |
|
2980
FVCBankcorp
FVCB
$337M
| $649K | ﹤0.01% |
45,710
-2,170
| -5% | -$26.3K |
|
2981
Codexis
CDXS
$173M
| $646K | ﹤0.01% |
211,734
+59,327
| +39% | +$127K |
|
2982
British American Tobacco
BTI
$121B
| $646K | ﹤0.01% |
22,048
-20,049
| -48% | -$610K |
|
2983
OptimizeRx
OPRX
$130M
| $643K | ﹤0.01% |
44,903
| – | – |
|
2984
Seer Inc
SEER
$117M
| $639K | ﹤0.01% |
329,430
+3,640
| +1% | +$6.47K |
|
2985
PLAYSTUDIOS Inc
MYPS
$76.2M
| $636K | ﹤0.01% |
234,583
-1,519
| -0.6% | -$4.14K |
|
2986
Zevra Therapeutics
ZVRA
$675M
| $630K | ﹤0.01% |
96,130
+5,698
| +6% | +$26.6K |
|
|
GBIO
2987
DELISTED
Generation Bio
GBIO
| $629K | ﹤0.01% |
38,148
+487
| +1% | +$8.49K |
|
|
ITI
2988
DELISTED
Iteris, Inc.
ITI
| $620K | ﹤0.01% |
119,272
| – | – |
|
2989
Kodak
KODK
$987M
| $618K | ﹤0.01% |
158,529
-7,220
| -4% | -$27.8K |
|
2990
Nektar Therapeutics
NKTR
$2.56B
| $618K | ﹤0.01% |
72,928
+1,325
| +2% | +$10K |
|
2991
Workhorse Group
WKHS
$33.9M
| $618K | ﹤0.01% |
572
+34
| +6% | +$40.7K |
|
2992
Viemed Healthcare
VMD
$353M
| $615K | ﹤0.01% |
78,403
+369
| +0.5% | +$2.68K |
|
2993
Red Violet
RDVT
$1.09B
| $615K | ﹤0.01% |
30,805
-1,290
| -4% | -$25.7K |
|
2994
Northeast Community Bancorp
NECB
$373M
| $615K | ﹤0.01% |
34,676
-1,611
| -4% | -$26.2K |
|
|
ORAN
2995
DELISTED
Orange
ORAN
| $615K | ﹤0.01% |
53,800
+21,969
| +69% | +$258K |
|
2996
Capital Bancorp
CBNK
$619M
| $611K | ﹤0.01% |
25,241
| – | – |
|
2997
Plumas Bancorp
PLBC
$437M
| $611K | ﹤0.01% |
14,770
| – | – |
|
|
BRT
2998
BRT Apartments
BRT
$266M
| $610K | ﹤0.01% |
32,808
-38,090
| -54% | -$674K |
|
2999
Climb Global Solutions
CLMB
$520M
| $609K | ﹤0.01% |
44,436
| – | – |
|
3000
Commercial Vehicle Group
CVGI
$132M
| $609K | ﹤0.01% |
86,851
| – | – |
|
Similar funds
Charles Schwab's Q4 2023 Portfolio in Review
As of Q4 2023, Charles Schwab held 3,619 positions worth $394B, up 13% from $349B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 3.5%. Charles Schwab opened 44 new positions and exited 81, leaving the 3,619-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2023 buy was Janus Henderson Mortgage-Backed Securities ETF: 7,612,323 shares worth $350M.
- Charles Schwab added most to Merck in Q4 2023, an estimated $491M increase.
- Charles Schwab's biggest Q4 2023 reduction was Novartis, cutting an estimated $409M.
- Charles Schwab fully exited Activision Blizzard in Q4 2023, selling an estimated $343M.
- Charles Schwab's ten largest holdings make up 19% of its $394B portfolio in Q4 2023.
- Charles Schwab opened 44 new positions and closed 81 in Q4 2023.
- Charles Schwab's portfolio value rose 13% quarter-over-quarter to $394B.
Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.